Older adults at risk of dementia who received hands-on coaching improved their memory and thinking substantially more than those given general health recommendations, according to a two-year randomized trial published in The Lancet and presented at the Alzheimer's Association International Conference in London.
The difference was 55 percent on a composite measure of global cognition. That figure is drawing attention because it isolates something researchers have suspected but rarely tested directly: the value of structure and supervision, separate from the value of the healthy behaviors themselves.
One point deserves emphasis before anything else. Both groups in this trial received a lifestyle program, and the researchers reported that both improved. The comparison was not between an intervention and doing nothing. It was between an intensively supported version and a lighter-touch version, and the intensive one won.
The Design and What Separated the Two Groups
The trial, known as LatAm-FINGERS, enrolled 1,065 adults aged 60 to 77 at 12 sites across 11 countries: Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, the Dominican Republic, Ecuador, Mexico, Peru and Uruguay. It was a single-blind, multicenter randomized controlled trial funded by the Alzheimer's Association and part of the World-Wide FINGERS network.
The Systematic Lifestyle Intervention group of 539 participants received continuous coaching. That meant supervised exercise, nutrition counseling built on an adapted MIND diet, computerized cognitive training, cardiovascular risk monitoring, and 38 group meetings designed to build social connection and accountability.
The Flexible Lifestyle Intervention group of 526 participants received periodic health education and general lifestyle recommendations. Over two years, they attended four group meetings covering diet, physical activity, cognitive and social engagement, and vascular risk. They received no continuing coaching or supervision.
After two years, the structured group showed significantly larger improvements not only in global cognition but in memory, executive function, and processing speed.
No American Participants Were Enrolled
This trial was conducted entirely in Latin America, and readers in the United States should understand what that does and does not mean for them.
The work builds on U.S. POINTER, the American trial testing a similar multidomain approach, and was announced by the conference organizers alongside the journal publication. The researchers deliberately adapted rather than translated. Exercise options included salsa and tango and outdoor group workouts in public parks. Nutrition counseling leaned on regional foods including avocado, quinoa, açaí, aguaymanto, chia and pumpkin seeds. Extra support went to participants with limited experience using digital technology.
Lucia Crivelli, the study's lead author and a principal investigator at Fleni, a neurological institute in Buenos Aires, said the team "did not simply translate the U.S. POINTER model into Spanish and Portuguese." Multinational working groups decided which components had to stay standardized and which could be tailored to local culture, climate, food availability and technology access.
Laura D. Baker, a professor of gerontology and geriatrics at Wake Forest University School of Medicine and the U.S. POINTER principal investigator, framed the American relevance in terms of reach. A second strong result in a different part of the world, she said, "suggests that the U.S. POINTER formula can be adapted for anybody." She added that she expects the structured program to work in engaging Latino and Hispanic communities in the United States.
The Evidence Check Before Anyone Changes Routines
This is a randomized controlled trial published in a major journal, which places it well above observational research. Several limitations still shape what it can support.
The 55 percent figure is a relative difference between two active treatment arms on a composite cognitive score. It is not an absolute measure of clinical benefit, and it does not describe how much better anyone's memory got in daily life. Composite cognitive scores are research instruments, not diagnoses.
The trial ran two years. Dementia develops over decades, and improved cognitive test performance over two years is not the same as preventing dementia. Neither this trial nor U.S. POINTER has shown a reduction in dementia diagnoses, a point a companion Lancet commentary also takes up.
The trial was single-blind, meaning participants knew which program they were in. In behavioral research that raises the possibility that expectation and engagement contributed to results, particularly for a group attending 38 meetings compared with four.
Current medical guidance has not changed on the basis of this study. Heather M. Snyder, senior vice president of medical and scientific relations at the Alzheimer's Association, described the finding as an addition to accumulating evidence rather than a new recommendation, saying the key message is that "structure and social support matter." She noted that addressing multiple lifestyle factors may eventually be paired with emerging drug therapies.
Readers should also note the funding relationship. The Alzheimer's Association funded the trial, runs U.S. POINTER, and hosts the conference where the results were presented.
The Practical Takeaway for Older Adults and Families
The most useful message here is not a specific diet or exercise prescription. It is that going it alone appears to work less well than doing the same things with support, a reading summarized by Alzheimer Europe in its account of the trial.
For families helping an older relative, that suggests favoring structured programs over handing someone a pamphlet. Group exercise classes, senior center programming, supervised fitness sessions, and organized social activities all supply the accountability the structured arm received. Many are available at low or no cost through local senior centers, YMCA programs, and Area Agencies on Aging.
People concerned about memory changes should raise them with a clinician rather than self-managing. Cognitive symptoms have many causes, including medication effects, sleep apnea, thyroid disease, depression, and vitamin deficiencies, several of which are treatable.
Nobody should stop or change prescribed medication based on this trial. Cardiovascular risk monitoring was part of the structured program, not a replacement for it.
The next questions researchers face are whether these cognitive gains persist, whether they eventually translate into fewer dementia diagnoses, and whether the structured model can be delivered affordably at population scale. Those answers will take years.
Key Questions Answered
What did the trial actually compare? Two lifestyle programs. One provided continuous coaching and 38 group meetings; the other provided general recommendations and four meetings. Both groups received an intervention.
Does this prove lifestyle changes prevent dementia? No. The trial measured cognitive test performance over two years. It did not measure dementia diagnoses, and current medical guidance has not changed.
Were Americans included in the study? No. All 1,065 participants were enrolled at sites in 11 Latin American countries. The findings build on the separate U.S. POINTER trial.
What does a 55 percent greater improvement mean? It is a relative difference between the two groups on a composite global cognition score, not a measure of how much daily memory improved.
What was in the structured program? Supervised exercise, nutrition counseling using an adapted MIND diet, computerized cognitive training, cardiovascular risk monitoring, and regular group meetings.
Where can older adults find similar support? Senior centers, Area Agencies on Aging, YMCA programs, and hospital wellness programs often offer group exercise and social programming at low or no cost.
Who funded the research? The Alzheimer's Association funded the trial and also runs U.S. POINTER and the conference where results were presented, a relationship readers should weigh.
